Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3927]

Discontinuing statins near the end of life is safe, improves patient quality of...

Prof Amy P. Abernethy - Duke University School of Medicine, Durham, USA

Discontinuing statins near the end of life is safe, improves patient quality of life ( Prof Amy P. Abernethy - Duke University School of Medicine, Durham, USA )

Phase III SELECT trial shows lenvatinib to be effective in resistant thyroid...

Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France

Phase III SELECT trial shows lenvatinib to be effective in resistant thyroid cancer ( Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France )

Inhibition of PD-L1 using drug MPDL3280A for patients with metastatic...

Prof Thomas Powles - Barts Health, London, UK

Inhibition of PD-L1 using drug MPDL3280A for patients with metastatic urothelial bladder cancer ( Prof Thomas Powles - Barts Health, London, UK )

Blinatumomab shown to be beneficial in relapsed/refractory B-precursor acute...

Prof Max Topp - Würzburg University Hospital, Würzburg, Germany

$Blinatumomab shown to be beneficial in relapsed/refractory B-precursor acute lymphoblastic leukaemia ( Prof Max Topp - Würzburg University Hospital, Würzburg, Germany )$

Regorafenib shows early promise in colorectal candidates unable to undergo chemo

Dr Enrique Grande - Hospital Ramon y Cajal, Madrid, Spain

Regorafenib shows early promise in colorectal candidates unable to undergo chemo ( Dr Enrique Grande - Hospital Ramon y Cajal, Madrid, Spain )

Lower-dose radiation safe for certain lower-risk, HPV-positive head and neck...

Prof Anthony Cmelak - Vanderbilt-Ingram Cancer Center, Nashville, USA

Lower-dose radiation safe for certain lower-risk, HPV-positive head and neck cancers ( Prof Anthony Cmelak - Vanderbilt-Ingram Cancer Center, Nashville, USA )

ASCO 2014 roundup

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ASCO 2014 roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Lapatinib not found to be beneficial in head and neck cancer with high risk of...

Prof Kevin Harrington - Institute of Cancer Research, London, UK

Lapatinib not found to be beneficial in head and neck cancer with high risk of recurrence ( Prof Kevin Harrington - Institute of Cancer Research, London, UK )

Addition of docetaxel to initial hormone therapy substantially improves...

Dr Michael Carducci - Johns Hopkins School of Medicine, Baltimore, USA

Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer ( Dr Michael Carducci - Johns Hopkins School of Medicine, Baltimore, USA )

T-VEC injections into melanoma lesions show significant response rate

Prof Kevin Harrington - Institute of Cancer Research, London, UK

T-VEC injections into melanoma lesions show significant response rate ( Prof Kevin Harrington - Institute of Cancer Research, London, UK )

Impact of cytotoxics on pregnancy needs to be better understood

Dr Shahid Gilani - University Hospital of North Staffordshire, Stoke-on-Trent...

Impact of cytotoxics on pregnancy needs to be better understood ( Dr Shahid Gilani - University Hospital of North Staffordshire, Stoke-on-Trent, UK )

Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early...

Dr Edith Perez - Mayo Clinic, Rochester, USA

Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early- stage HER2-positive breast cancer ( Dr Edith Perez - Mayo Clinic, Rochester, USA )

More from ecancer